Loading...
Luminex Corporation
LMNX•NASDAQ
Healthcare
Medical - Instruments & Supplies
$36.99
$0.00(0.00%)

Financial performance has remained strong, with revenue growing from $109.52M in Q2 2020 to $110.69M in Q1 2021. Gross profit continued to perform well, with margins at 60% in the latest quarter. Operating income reached $13.46M in Q1 2021, holding a steady 12% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $21.03M. Net income rose to $9.08M, keeping EPS at $0.20. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan